FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Authors say patients even with COVID-19 should continue taking cardiovascular drugs as prescribed
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
Pfizer cited data from Israel showing the vaccine is declining in effectiveness as the highly contagious Delta variant circulates
Risk for Atherosclerotic CVD Increased With South Asian Ancestry
Higher risk persisted after adjustment for broad range of clinical, anthropometric, and lifestyle risk factors
ACIP: Benefits of mRNA COVID-19 Vaccines Outweigh Risks for ≥12s
After reviewing evidence, including data on risks for myocarditis, vaccination benefits outweigh risks for all populations
Omega-3 Fatty Acids Tied to Better Cardiovascular Outcomes
Cardiovascular risk reduction more prominent with EPA monotherapy versus EPA + DHA therapy
Longer Reproductive Window Could Up Risk for Alzheimer Disease
Authors suggest longer exposure to endogenous estrogen may be associated with increased levels of Alzheimer disease biomarkers
Androgenetic Alopecia May Reduce Health-Related Quality of Life
Authors say patients with androgenetic alopecia may need psychological, psychosocial support
Health Equity Not Adequately Addressed in COVID-19 Vaccine Distribution
Minority group representatives present in only a minority of state vaccine plans
